MED LIFE SA |
End-of-day quote
Other stock markets
|
||
| - RON | - |
|
| Apr. 03 | Med Life S.A. (BVB:M) acquired an unknown majority stake in Personal Genetics Srl. | CI |
| Feb. 29 | Med Life S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2023 | 2.21B 472M | Sales 2024 * | 2.49B 532M | Capitalization | 2.13B 454M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | 22 4.7 | EV / Sales 2023 | 0.95 x |
| Net Debt 2023 * | 995M 212M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.85 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
102
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 42.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Med Life SA
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Mihail Marcu
CEO | Chief Executive Officer | 53 | 06-07-31 |
Adrian Lungu
DFI | Director of Finance/CFO | - | - |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ovidiu Fer
BRD | Director/Board Member | 40 | 20-11-30 |
| Director/Board Member | 68 | 17-08-31 | |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
MedLife S.A. specializes in medical diagnosis and treatment services for enterprises and individuals. The group is active in the fields of orthopedics and traumatology, general and plastic surgery, spinal surgery, gynecology, paediatrics and maternity services.
At the end of 2021, MedLife S.A. operated 80 clinics, 11 multi- and mono-disciplinary hospitals, 34 medical laboratories (near 200 sampling centres), 17 dental clinics and 22 pharmacies located in Romania.
Calendar
2024-04-28
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -12.58% | 86.92B | |
| +15.96% | 85.34B | |
| +12.75% | 29.88B | |
| -11.16% | 17.1B | |
| -5.20% | 15.24B | |
| -7.59% | 14.29B | |
| +0.27% | 12.38B | |
| -31.58% | 12.1B | |
| +23.88% | 11.4B |
